Comparison of supportive regulatory measures for pediatric medical device development in Japan and the United States

Author:

Takahashi Sara,Iwasaki Kiyotaka,Shirato Haruki,Ho Mami,Umezu Mitsuo

Abstract

AbstractFurther development of medical devices for children is required in Japan, but the development of such devices is delayed compared to that of medical devices for adults. Herein, we investigated policies for advancing the development of pediatric medical devices in Japan and the United States. Considering the achievements of each policy, we proposed a strategy to promote further development of pediatric medical devices in Japan. We investigated policies for supporting the development of pediatric medical devices and approved cases in Japan and the United States by searching contents of websites of regulatory bodies and other related administrations, and scientific papers. We found the main six policies in Japan and nine main policies in the United States for the development of pediatric medical devices. In the United States, various measures have initiated mainly in the 2000s, while in Japan, the main measures have been in place since 2013. Similarities were found in both countries, such as subsidies for application fees and research and development expenses, exemption of requirements for regulatory approval, and priority review and consultation by the regulatory body. Our study revealed that there are similarities in initiatives by both countries. To promote further development of pediatric medical devices in the future, improvements to expediting the review process to approval by the regulatory body, global development, and implementation of alternative measures to ensure the efficacy and safety of the device instead of large-scale clinical trials should be anticipated through cooperation among industry, government, and academia.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Biomedical Engineering,Biomaterials,Medicine (miscellaneous)

Reference58 articles.

1. Pharmaceuticals and Medical Devices Agency, Descriptive pamphlet. https://www.pmda.go.jp/files/000219906.pdf(in Japanese). Accessed June17, 2020.

2. Food and Drug Administration, CDRH Management Directory by Organization. https://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDRH/CDRHOffices/ucm127854.htm. Accessed June17, 2020.

3. Pharmaceuticals and Medical Devices Agency, Approved brand-new medical devices in Japan, https://www.pmda.go.jp/review-services/drug-reviews/review-information/devices/0018.html(in Japanese). Accessed June17, 2020.

4. Ministry of Health, Labour and Welfare, Pharmaceuticals and medical devices. https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/iyakuhin/index.html(in Japanese). Accessed June17, 2020.

5. Ministry of Health, Labour and Welfare, Study Group on the Early Introduction of Medical Devices, etc. with High Medical Need. https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000095066.html(in Japanese). Accessed June17, 2020.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3